Fig. 2

Synthesis and characterization of A6-NP. (A) SDS-PAGE of HSA, 2.3%A6-HSA and 5.5%A6-HSA, respectively. (B) MADLI-TOF-MS of HSA, 2.3%A6-HSA and 5.5%A6-HSA, respectively. (C-E) TEM image of NP, 2.3%A6-NP and 5.5%A6-NP, respectively. (F-H) Hydrodynamic size of NP, 2.3%A6-NP and 5.5%A6-NP, respectively. (I) X-ray diffraction patterns: a G2111, b the physical mixture of blank-NP and G2111, c the physical mixture of blank-2.3%A6-NP and G2111, d the physical mixture of blank-5.5%A6-NP and G2111, e NP, f 2.3%A6-NP, g 5.5%A6-NP. (J) In vitro drug release curves (n = 3). (K) The stability of nanoparticles within 7 days at 4 °C